Funding for this research was provided by:
National Cancer Institute (P50 CA244433-01)
Received: 14 February 2023
Accepted: 2 August 2023
First Online: 24 August 2023
: This study has been approved by the Harvard Longwood Area Office of Human Research Administration. The Harvard Longwood Area Office of Human Research Administration granted a waiver of documentation of consent for adult FQHC staff participants because the research presents no more than minimal risk to participants and involves no procedures for which written consent is normally required outside of the research context. Verbal consent was collected for qualitative interviews and consent language was built into introductory survey text.
: Consent for including de-identified individual quotations was gathered as part of the interview verbal consenting procedures. The confidentiality section of the consent script read: “The transcript of this interview will be stripped of your name. We will not report your name or company in any published results, but rather use job titles or roles.” We followed this approach in this paper and further anonymized data with more generic job titles (e.g., “leader”) when titles were deemed too specific and identifiable by the study team.
: The authors declare that they have no competing interests.